Arbutus Biopharma Corp (NASDAQ:ABUS)

2.05
Delayed Data
As of Jun 05
 +0.01 / +0.49%
Today’s Change
0.82
Today|||52-Week Range
3.66
-26.26%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Arbutus Biopharma Corp have a median target of 5.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +143.90% increase from the last price of 2.05.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Arbutus Biopharma Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$1.4M
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.20%
 
 
 
 
 
 
Growthannually 69.20%
 
 
 
 
 
 

Sales

Growthquarterly -4.58%
 
 
 
 
 
 
Growthannually 2.03%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.